GENEONELIFESCIENCEGENEONELIFESCIENCEGENEONELIFESCIENCE

GENEONELIFESCIENCE

No trades
See on Supercharts

011000 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

GeneOne Life Science, Inc. engages in the research, development, and manufacture of deoxyribonucleic acid (DNA) vaccines for the prevention and treatment of diseases. Its products include VGX-3400, VGX-3500, and fluorine. Its service includes process cost analysis, sterility testing, research batch production, strain selection, cell bank characterization, and others. It also conducts pre-clinical trials for the treatment of hepatitis C. In addition, it is involved in contract manufacturing activities for pre-clinical and clinical trials for companies and institutions. The company was founded on January 27, 1976 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
011000 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company